Torrent Pharma Reports 26 Decline in Q4 Profit on Acquisition and Severance Costs Board Approves 5000 Crore QIP Polar Semiconductor and Nexperia Forge Power MOSFET Manufacturing Partnership to Strengthen Global Supply Chains Trump Postpones AI Executive Order Cites Concerns Over Potential Blocker Regulatory Crackdown Intensifies States Challenge Prediction Market Platforms Financial Services Roundup Market Talks Highlight Experian and SoFi Technologies Baird Raises Price Target on RideNow Group Citing Strong SameStore Sales Performance MTB Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher UGP Q1 2026 Earnings Strong EPS Beat of 2608 Surprise Stock Slips Slightly Perdoceo Education Corporation PRDO Q1 2026 Earnings EPS Surpasses Estimates with 5 Surprise James Hardie Industries JHX Q1 2026 Earnings EPS Misses Estimates Amid Sluggish Demand Team Inc TISI Q1 2026 Earnings Loss Per Share of 276 Reported Stock Edges Higher RNR Q1 2026 Earnings Strong Underwriting and Investment Results Drive EPS Beat Puma Biotechnology PBYI Edges Higher Amidst Key Support and Resistance Levels Southern First Bancshares SFST Holds Steady Near Support 5762 Perion Network PERI Edges Higher Testing Key Resistance Levels BTCS Inc BTCS Slips 35 Key Support Levels in Focus as Bearish Pressure Persists Agilysys Inc AGYS Surges Over 4 as Buyers Test Key Resistance SP 500 Inches Higher as Healthcare and Tech Lead Broad Gains IP Q1 2026 Earnings Industrial Packaging Giant Beats EPS Estimates Amid Cost Disciplines Kemper Corporation KMPR Holds Steady Near Support as Consolidation Continues Allogene Therapeutics Edges Higher Testing Key Resistance at 21 GDL Fund GDL Holds Steady Near Midpoint of Range After Slight Uptick Karyopharm Therapeutics KPTI Edges Higher as Volume Picks Up Key Resistance Level Ahead Atlantic American Corporation AAME Rises 14 as Shares Rebound From Key Support at 208 Cheniere Energy Partners CQP Holds Steady Modest Gains Amid Sector Stability Midland States Bancorp Preferred Shares MSBIP Hold Steady at 2543 Amidst Stability Rocket Pharmaceuticals RCKT Posts Modest Gains as Stock Tests Key Support Levels